Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-052872
Filing Date
2023-10-16
Accepted
2023-10-16 16:51:58
Documents
2
Period of Report
2023-10-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1544
2 POA DOCUMENT poa.txt EX-24 3940
  Complete submission text file 0001209191-23-052872.txt   6835
Mailing Address 3000 KENT AVENUE; SUITE A1-100 WEST LAFAYETTE IN 47906
Business Address
Meek David D. (Reporting) CIK: 0001555337 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39344 | Film No.: 231327768

Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Issuer) CIK: 0001805890 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)